4 Results for "

NRP1-b1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "NRP1-b1" in MCE Product Catalog:

12
12 Publications Verification
Cat. No.: HY-10799
CAS No.: 1210945-69-9
Purity:  98.03%
Target:  

Complement System

Research Areas:  

Cancer

EG00229 is a neuropilin 1 (NRP1) receptor antagonist. EG00229 selectively inhibits VEGF-A binding to NRP1 b1 domain with an IC50 of 3 μM, but has no effect on VEGFA binding to VEGFR-1 and VEGFR-2 .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-112151
CAS No.: 2227996-00-9
Target:  

Complement System

Research Areas:  

Cancer

EG01377 is a potent, bioavailable and selective inhibitor of neuropilin-1 (NRP1), with a Kd of 1.32 μM, and IC50s of both 609 nM for NRP1-a1 and NRP1-b1. EG01377 has antiangiogenic, antimigratory, and antitumor effects .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-112151A
CAS No.: 2749438-61-5
Purity:  98.98%
Target:  

Complement System

Research Areas:  

Cancer

EG01377 dihydrochloride is a potent, bioavailable and selective inhibitor of neuropilin-1 (NRP1), with a Kd of 1.32 μM, and IC50s of 609 nM for both NRP1-a1 and NRP1-b1. EG01377 dihydrochloride has antiangiogenic, antimigratory, and antitumor effects .
loading...
    loading...
Cat. No.: HY-10799R
CAS No.: 1210945-69-9
Research Areas:  

Cancer

EG00229 trifluoroacetate (Standard) is the analytical standard of EG00229 (trifluoroacetate) (HY-10799). This product is intended for research and analytical applications. EG00229 is a neuropilin 1 (NRP1) receptor antagonist. EG00229 selectively inhibits VEGF-A binding to NRP1 b1 domain with an IC50 of 3 μM, but has no effect on VEGFA binding to VEGFR-1 and VEGFR-2 .
loading...
    loading...